Glycom A/S

Glycom A/S

Glycom A/S

Overview
Date Founded

2005

Headquarters

Diplomvej 373,1st Floor,Kongens Lyngby, Zealand 2800

Type of Company

Private

Industries

Biotechnology
Chemicals

Company Description

Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark Von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark.

Contact Data
Trying to get in touch with decision makers at Glycom A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Portfolio Manager

Board of Directors

Managing Partner at FIH Partners A/S

Professor at University of Hamburg

Portfolio Manager at Acesion Pharma ApS

Paths to Glycom A/S
Potential Connections via
Relationship Science
You
Glycom A/S
Recent Transactions
Details Hidden

Koninklijke DSM NV purchases Glycom A/S

Details Hidden

Danske Bank A/S purchases Glycom A/S

Details Hidden

Glycom A/S purchases Vitalys I/S from Dansk Landbrugs Grovvareselskab AmbA

Transaction Advisors
Investment Advisor

Advised onKoninklijke DSM NV purchases Glycom A/S

Investment Advisor

Advised onKoninklijke DSM NV purchases Glycom A/S

Investment Advisor

Advised onDanske Bank A/S purchases Glycom A/S

Investors
Details Hidden

Co-Founder at Glycom A/S

Details Hidden

Co-Founder at Glycom A/S

Details Hidden

Founder at Glycom A/S

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Glycom A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Glycom A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Glycom A/S.